| Quote | Spy AUXL NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Auxilium Pharma Posts Q3 loss of $0.34
AUXL Linked by StreetInsider - October 28, 07:45AM from (www.streetinsider.com) more ...
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results and Operational Highlights
AUXL Linked by marketwire - October 28, 07:14AM from (www2.marketwire.com) Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and more ...
Auxilium Pharmaceuticals to Announce Third Quarter 2009 Results and Conduct Conference Call on Wednesday, October 28, 2009
AUXL Linked by marketwire - October 14, 07:00AM from (www2.marketwire.com) Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the third more ...
U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
AUXL Linked by marketwire - September 16, 03:46PM from (www2.marketwire.com) Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Arthritis more ...
Auxilium Pharmaceuticals "buy," target price raised
AUXL Linked by newratings - September 15, 01:13PM from (www.newratings.com) NEW YORK, September 15 (newratings.com) - Analysts at Deutsche Bank Securities reiterate their "buy" rating on more ...
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational Highlights
AUXL Linked by marketwire - August 06, 06:00AM from (www2.marketwire.com) Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced financial results and more ...
Auxilium Pharmaceuticals to Announce Second Quarter 2009 Results and Conduct Conference Call on Thursday, August 6, 2009
AUXL Linked by marketwire - July 23, 07:29AM from (www2.marketwire.com) Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the second more ...
Auxilium Pharmaceuticals initiated with "sell"
AUXL Linked by newratings - July 20, 01:43PM from (www.newratings.com) NEW YORK, July 20 (newratings.com) - Analysts at Caris & Co initiate coverage of Auxilium Pharmaceuticals Inc (ticker: more ...
Auxilium Bullish Call Action
AUXL Posted by Options_Hawk - June 27, 09:56AM Auxillium Pharma (AUXL) trades a 2,00 contract bullish risk reversal for $1.80, trader buying the September $35 calls, financed more ...
Auxilium Pharmaceuticals Selects Cegedim Dendrite SaaS CRM Solution
AUXL Linked by BusinessWire - June 18, 12:00PM from (www.businesswire.com) Cegedim Dendrite today announced that Auxilium Pharmaceuticals (NASDAQ: AUXL) has selected and deployed the Software-as-a-Service more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|